Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer

Clinical trial NCT00003313 · COMPLETED

Trial details

NCT number: NCT00003313
Sponsor: Radiation Therapy Oncology Group
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Drug/Agent Toxicity by Tissue/Organ Lung Cancer Oral Complications Radiation Toxicity

Start date: 1998-09-01
Primary completion: 2002-07-01
Enrollment: 243

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.